Williams Jones & Associates’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-7,284
| Closed | -$367K | – | 457 |
|
|
2018
Q2 | $367K | Sell |
7,284
-240
| -3% | -$12.1K | 0.01% | 323 |
|
|
2018
Q1 | $367K | Hold |
7,524
| – | – | 0.01% | 320 |
|
|
2017
Q4 | $334K | Sell |
7,524
-80
| -1% | -$3.55K | 0.01% | 341 |
|
|
2017
Q3 | $386K | Buy |
7,604
+1,204
| +19% | +$61.1K | 0.01% | 312 |
|
|
2017
Q2 | $345K | Sell |
6,400
-1,980
| -24% | -$107K | 0.01% | 319 |
|
|
2017
Q1 | $442K | Hold |
8,380
| – | – | 0.01% | 287 |
|
|
2016
Q4 | $403K | Sell |
8,380
-400
| -5% | -$19.2K | 0.01% | 293 |
|
|
2016
Q3 | $473K | Hold |
8,780
| – | – | 0.01% | 276 |
|
|
2016
Q2 | $476K | Buy |
8,780
+5,600
| +176% | +$304K | 0.01% | 269 |
|
|
2016
Q1 | $161K | Buy |
+3,180
| New | +$161K | 0.01% | 311 |
|
|
2015
Q2 | – | Sell |
-3,500
| Closed | -$202K | – | 386 |
|
|
2015
Q1 | $202K | Buy |
+3,500
| New | +$202K | 0.01% | 352 |
|
|
2014
Q4 | – | Sell |
-3,500
| Closed | -$201K | – | 394 |
|
|
2014
Q3 | $201K | Hold |
3,500
| – | – | 0.01% | 310 |
|
|
2014
Q2 | $234K | Sell |
3,500
-78,858
| -96% | -$5.27M | 0.01% | 292 |
|
|
2014
Q1 | $5.5M | Buy |
82,358
+78,752
| +2,184% | +$5.26M | 0.11% | 127 |
|
|
2013
Q4 | $241K | Hold |
3,606
| – | – | 0.01% | 267 |
|
|
2013
Q3 | $226K | Sell |
3,606
-27,665
| -88% | -$1.73M | 0.01% | 268 |
|
|
2013
Q2 | $1.95M | Buy |
+31,271
| New | +$1.95M | 0.1% | 135 |
|